Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 410
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05409326 | A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects | ||
| NCT04236362 | A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer | ||
| NCT06351150 | Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock | ||
| NCT04405505 | A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC) | ||
| NCT07044908 | TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal Cancer | ||
| NCT06754891 | Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease | ||
| NCT03703596 | Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC | ||
| NCT05292196 | A Phase II Clinical Trial of TQC3721 Suspension for Inhalation | ||
| NCT05252078 | Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients | ||
| NCT03714568 | Pharmacokinetic and Tolerance Study of TQ-A3326 in Healthy Participants. | ||
| NCT05045872 | Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance Imaging | ||
| NCT03510767 | A Study of TQ-B3525 on Tolerance and Pharmacokinetics | ||
| NCT07011186 | A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies | ||
| NCT05998941 | A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer | ||
| NCT03456466 | Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma | ||
| NCT05344729 | Clinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult Subjects | ||
| NCT06431490 | A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer | ||
| NCT06672276 | To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency | ||
| NCT05834543 | Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma | ||
| NCT06702618 | Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer | ||
| NCT06682169 | Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease | ||
| NCT05959694 | A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) . | ||
| NCT05862337 | Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence. | ||
| NCT06943677 | A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant Tumors | ||
| NCT05262101 | Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade Sarcoma | ||
| NCT04339400 | A Study of TQ05105 Tablets in Subjects With Myeloproliferative Neoplasms | ||
| NCT04768699 | Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia. | ||
| NCT05460481 | Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors | ||
| NCT04056754 | Study of Abiraterone Acetate in Subjects With Metastatic Castration Resistant Prostate Cancer | ||
| NCT04619563 | A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer Patients | ||
| NCT04975204 | A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors | ||
| NCT01795716 | Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body | ||
| NCT04836663 | A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors | ||
| NCT05849727 | A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis | ||
| NCT06115902 | A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer | ||
| NCT05610202 | Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects | ||
| NCT04895345 | A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma | ||
| NCT04373395 | Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML) | ||
| NCT04854681 | Phase 1 Trial of the TQB2928 Injection in Patients With Advanced Cancers | ||
| NCT05353179 | Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers | ||
| NCT06143423 | A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects. | ||
| NCT03986073 | Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus | ||
| NCT04080843 | Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients | ||
| NCT02825563 | A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients | ||
| NCT06165809 | A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer | ||
| NCT06344351 | A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer | ||
| NCT02332499 | Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703) | ||
| NCT03800706 | A Phase II Study to Evaluate the Safety and Efficacy of TQB2450 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma | ||
| NCT05975645 | A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC). | ||
| NCT04523285 | A Phase I Study of TQB728 Tablets on Tolerance and Pharmacokinetics |
